RNA Silencing Technologies in Drug Discovery and Target Validation

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|2|1|1-18

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.2, Iss.1, 2005-02, pp. : 1-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Discovery and Target Validation

By  

Cells Tissues Organs, Vol. 169, Iss. 3, 2001-06 ,pp. : 265-271

Karger

Access to resources Recommend Favorite

Target validation and drug discovery using genomic and protein–protein interaction technologies

By Pillutla Renuka C   Fisher Paul B   Blume Arthur J   Goldstein Neil I  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 4, 2002-08 ,pp. : 517-531

Informa Healthcare

Access to resources Recommend Favorite

Target Validation for Drug Discovery in Parasitic Organisms

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 5, 2002-05 ,pp. : 425-438

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Emerging Genomics and Proteomics Technologies in Cancer Drug Target Discovery

By  

Current Cancer Drug Targets, Vol. 4, Iss. 2, 2004-03 ,pp. : 111-124

Bentham Science Publishers

Access to resources Recommend Favorite

Mouse genetics in drug target discovery and validation: no simple answers to complex problems

By Russ AP   Grosse J  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 10, 2007-10 ,pp. : 1379-1387

Informa Healthcare

Access to resources Recommend Favorite